Evidence map›Paper›PMID 28439500›Full record

ArticleFrontiers in cellular and infection microbiology2017

Chronic

Maria C Souza, Denise M Fonseca, Alexandre Kanashiro, Luciana Benevides, Tiago S Medina, Murilo S Dias, Warrison A Andrade, Giuliano Bonfá, Marcondes A B Silva, Aline Gozzi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Transboundary and emerging diseases · 2025
    Article
  5. Potent In Vitro and In Vivo Effects ofTropical medicine and infectious disease · 2023
    Article
  6. The role ofFrontiers in cellular and infection microbiology · 2023
    Article
  7. Therapeutic Potential and Safety of theFrontiers in cellular and infection microbiology · 2022
    Article
  8. ChronicProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. In vitro and in vivo Anti-Infection and drug resistance · 2021
    Article
  10. Review
  11. Anti-Bioscience reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Maria C SouzaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Denise M FonsecaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Alexandre KanashiroDepartment of Pharmacology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Luciana BenevidesDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Tiago S MedinaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Murilo S DiasDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Warrison A AndradeDepartment of Medicine, University of Massachusetts Medical SchoolWorcester, MA, USA.
Giuliano BonfáDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Marcondes A B SilvaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Aline GozziDepartment of Internal Medicine, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Marcos C BorgesDepartment of Internal Medicine, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Ricardo T GazzinelliDepartment of Medicine, University of Massachusetts Medical SchoolWorcester, MA, USA.
José C Alves-FilhoDepartment of Pharmacology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Fernando Q CunhaDepartment of Pharmacology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
João S SilvaDepartment of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São PauloSão Paulo, Brazil.
Universidade de São Paulo · BRUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a severe syndrome that arises when the host response to an insult is exacerbated, leading to organ failure and frequently to death. How a chronic infection that causes a prolonged Th1 expansion affects the course of sepsis is unknown. In this study, we showed that mice chronically infected with

Indexed as

AnimalsCoinfectionDisease Models, AnimalInterferon-gammaMiceNitric OxideSepsisTh1 CellsTh2 CellsToxoplasmosisInterferon-gammaNitric Oxidechronic diseasecoinfectionsepsisseptic shockToxoplasma gondii

Identifiers

PMID28439500
PMCPMC5383667
OpenAlexW2604677899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.